Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

LIEBKE R HOPE — TAPESTRY PHARMACEUTICALS, INC insider: 1 transactions · InsiderLens

Home / Insiders / LIEBKE R HOPE

LIEBKE R HOPE

VP, General Counsel, Genomics at TAPESTRY PHARMACEUTICALS, INC · on record since Sep 4, 2003

Insider trading activity of LIEBKE R HOPE

Transactions on record: 1; since Sep 4, 2003

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Sep 4, 2003

Figures computed from official regulatory filings — methodology.

Companies where LIEBKE R HOPE has traded

TAPESTRY PHARMACEUTICALS, INC1 tx · Sep 4, 2003

Track record of LIEBKE R HOPE

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of LIEBKE R HOPE

Co-insiders of LIEBKE R HOPE

14159 capital (GP), LLCTAPESTRY PHARMACEUTICALS, INC
AINSWORTH STERLING PH DTAPESTRY PHARMACEUTICALS, INC
BAILEY ANNE LTAPESTRY PHARMACEUTICALS, INC
Baker Biotech Capital III (GP), LLCTAPESTRY PHARMACEUTICALS, INC
Baker Biotech Capital III (Z) (GP), LLCTAPESTRY PHARMACEUTICALS, INC
Baker Biotech Capital II (Z) (GP), LLCTAPESTRY PHARMACEUTICALS, INC
Baker Bros. Capital (GP), LLCTAPESTRY PHARMACEUTICALS, INC

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

BAKER FELIXTAPESTRY PHARMACEUTICALS, INC

BAKER JULIANTAPESTRY PHARMACEUTICALS, INC

BATT MARTINTAPESTRY PHARMACEUTICALS, INC

Cannon Martin ATAPESTRY PHARMACEUTICALS, INC

CARTER STEPHEN KTAPESTRY PHARMACEUTICALS, INC

ERICKSON EDWARD LTAPESTRY PHARMACEUTICALS, INC

FIEDLER BRUCE WTAPESTRY PHARMACEUTICALS, INC

GOLDMAN SACHS & COTAPESTRY PHARMACEUTICALS, INC

GOLDMAN SACHS GROUP INC/TAPESTRY PHARMACEUTICALS, INC

GOULD GEORGE MTAPESTRY PHARMACEUTICALS, INC

HAYES ARTHUR HULL JRTAPESTRY PHARMACEUTICALS, INC

LARSON KAI PTAPESTRY PHARMACEUTICALS, INC

LINK GORDON H JRTAPESTRY PHARMACEUTICALS, INC

Majoros Matthew JTAPESTRY PHARMACEUTICALS, INC

MARXE AUSTIN W & GREENHOUSE DAVID MTAPESTRY PHARMACEUTICALS, INC

MAZA ELLIOTT MTAPESTRY PHARMACEUTICALS, INC

MCCUDDEN BRIAN JTAPESTRY PHARMACEUTICALS, INC

OSTRO MARC JTAPESTRY PHARMACEUTICALS, INC

PERLE RICHARD NTAPESTRY PHARMACEUTICALS, INC

PICKER DONALD HTAPESTRY PHARMACEUTICALS, INC

PILIA PATRICIA PH DTAPESTRY PHARMACEUTICALS, INC

POLLACK ROBERT ETAPESTRY PHARMACEUTICALS, INC

Rowinsky Eric KTAPESTRY PHARMACEUTICALS, INC

SHAYKIN LEONARD PTAPESTRY PHARMACEUTICALS, INC

TANG CAPITAL MANAGEMENT LLCTAPESTRY PHARMACEUTICALS, INC

TANG CAPITAL PARTNERS LPTAPESTRY PHARMACEUTICALS, INC

TANG KEVIN CTAPESTRY PHARMACEUTICALS, INC

White JeffreyTAPESTRY PHARMACEUTICALS, INC

Company	Filed	Type	Qty	Price	Value · USD	Src
TAPESTRY PHARMACEUTICALS, INC	Sep 4, 2003	AwardD	60,000	1.55 USD	—	SEC